Navigating Schizophrenia Part 4: Improving Patient Outcomes and Quality of Life With Long-Acting Injectable Therapy

Navigating Schizophrenia Part 4: Improving Patient Outcomes and Quality of Life With Long-Acting Injectable Therapy

The goal of this activity is to improve clinicians understanding of the benefits and potential importance of use of LAI antipsychotic therapies in a treatment plan for patients living with schizophrenia.

  • Provider:Medscape, LLC
  • Activity Link: https://www.medscape.org/viewarticle/1001964
  • Start Date: 2024-12-19 06:00:00
  • End Date: 2024-12-19 06:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
    Nursing: 0.5 hours
  • Commercial Support: Source: Janssen (Any division) - Amount: 59616.0 - Is Kind Support: False
  • Activity Type: Other/Blended Learning
  • CME Finder Type: Other
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.